Clinical trial
Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation…
NCT00377923 · IBSA Institut Biochimique SA, Industry · Completed
Key facts
| NCT number | NCT00377923 |
|---|---|
| Title | Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers |
| Lead sponsor | IBSA Institut Biochimique SA, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Progesterone |
| Enrollment | 24 |
| Start date | Aug 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Sep 19, 2006 |
| Last update posted | Sep 20, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: